Coexpression of MYC and BCL-2 predicts prognosis in primary gastrointestinal diffuse large B-cell lymphoma

doi:10.3748/wjg.v21.i8.2433

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 8

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6695)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-6) series.

Item

Count

PDF

395

WORD

219

HTML

3310

Figures (1-5)

206

Tables (1-6)

165

Sum=4295

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1027

Download

1373

Sum=2400

Feb 28, 2015 (publication date) through Aug 27, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. Feb 28, 2015; 21(8): 2433-2442
Published online Feb 28, 2015. doi: 10.3748/wjg.v21.i8.2433

Full Size Figure Download Figure

Figure 5 Kaplan-Meier curves represent overall survival (OS) (A) and progression-free survival (B) according to presence of MYC and BCL-2 protein expression. OS: Overall survival; PFS: Progression-free survival.

Citation: Xia B, Zhang L, Guo SQ, Li XW, Qu FL, Zhao HF, Zhang LY, Sun BC, You J, Zhang YZ. Coexpression of MYC and BCL-2 predicts prognosis in primary gastrointestinal diffuse large B-cell lymphoma. World J Gastroenterol 2015; 21(8): 2433-2442
URL: https://www.wjgnet.com/1007-9327/full/v21/i8/2433.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i8.2433